Home/Filings/4/0001213900-25-050105
4//SEC Filing

KUCHARCHUK ANDREW ALBERT 4

Accession 0001213900-25-050105

CIK 0001870404other

Filed

Jun 1, 8:00 PM ET

Accepted

Jun 2, 4:57 PM ET

Size

5.5 KB

Accession

0001213900-25-050105

Insider Transaction Report

Form 4
Period: 2025-05-30
KUCHARCHUK ANDREW ALBERT
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-05-30+152,500152,500 total
    Exercise: $0.45Exp: 2035-05-29Common Stock (152,500 underlying)
Footnotes (1)
  • [F1]The shares underlying this option shall vest in equal monthly installments through June 4, 2027.

Documents

1 file

Issuer

CERO THERAPEUTICS HOLDINGS, INC.

CIK 0001870404

Entity typeother

Related Parties

1
  • filerCIK 0001654127

Filing Metadata

Form type
4
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 4:57 PM ET
Size
5.5 KB